Logo image of MSS

MAISON SOLUTIONS INC-A (MSS) Stock Fundamental Analysis

USA - NASDAQ:MSS - US5606671072 - Common Stock

0.8077 USD
-0.03 (-3.17%)
Last: 10/14/2025, 8:00:02 PM
0.84 USD
+0.03 (+4%)
After Hours: 10/14/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, MSS scores 3 out of 10 in our fundamental rating. MSS was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of MSS have multiple concerns. MSS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MSS has reported negative net income.
In the past year MSS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MSS reported negative net income in multiple years.
Of the past 5 years MSS 4 years had a positive operating cash flow.
MSS Yearly Net Income VS EBIT VS OCF VS FCFMSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 2M -2M 4M -4M -6M

1.2 Ratios

MSS's Return On Assets of -1.46% is on the low side compared to the rest of the industry. MSS is outperformed by 74.36% of its industry peers.
Looking at the Return On Equity, with a value of -10.60%, MSS is doing worse than 74.36% of the companies in the same industry.
Industry RankSector Rank
ROA -1.46%
ROE -10.6%
ROIC N/A
ROA(3y)0.36%
ROA(5y)0.56%
ROE(3y)72.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSS Yearly ROA, ROE, ROICMSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

Looking at the Gross Margin, with a value of 20.24%, MSS is in line with its industry, outperforming 41.03% of the companies in the same industry.
MSS's Gross Margin has improved in the last couple of years.
MSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.41%
GM growth 5YN/A
MSS Yearly Profit, Operating, Gross MarginsMSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

MSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MSS remains at a similar level compared to 1 year ago.
MSS has a better debt/assets ratio than last year.
MSS Yearly Shares OutstandingMSS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M 15M
MSS Yearly Total Debt VS Total AssetsMSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

MSS has an Altman-Z score of 1.47. This is a bad value and indicates that MSS is not financially healthy and even has some risk of bankruptcy.
MSS has a worse Altman-Z score (1.47) than 79.49% of its industry peers.
MSS has a debt to FCF ratio of 4.55. This is a neutral value as MSS would need 4.55 years to pay back of all of its debts.
MSS has a better Debt to FCF ratio (4.55) than 61.54% of its industry peers.
MSS has a Debt/Equity ratio of 0.98. This is a neutral value indicating MSS is somewhat dependend on debt financing.
MSS's Debt to Equity ratio of 0.98 is on the low side compared to the rest of the industry. MSS is outperformed by 64.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 4.55
Altman-Z 1.47
ROIC/WACCN/A
WACC7.98%
MSS Yearly LT Debt VS Equity VS FCFMSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

MSS has a Current Ratio of 0.58. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSS has a worse Current ratio (0.58) than 92.31% of its industry peers.
MSS has a Quick Ratio of 0.58. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.32, MSS is not doing good in the industry: 71.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.32
MSS Yearly Current Assets VS Current LiabilitesMSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

MSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.16%, which is quite impressive.
The Revenue has grown by 64.64% in the past year. This is a very strong growth!
MSS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.56% yearly.
EPS 1Y (TTM)65.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-274.13%
Revenue 1Y (TTM)64.64%
Revenue growth 3Y43.56%
Revenue growth 5YN/A
Sales Q2Q%-8.38%

3.2 Future

Based on estimates for the next years, MSS will show a very strong growth in Earnings Per Share. The EPS will grow by 35.62% on average per year.
Based on estimates for the next years, MSS will show a small growth in Revenue. The Revenue will grow by 5.97% on average per year.
EPS Next Y-100%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.08%
Revenue Next 2Y5.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MSS Yearly Revenue VS EstimatesMSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
MSS Yearly EPS VS EstimatesMSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2027 0.02 0.04 0.06 0.08 0.1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSS. In the last year negative earnings were reported.
MSS is valuated cheaply with a Price/Forward Earnings ratio of 6.66.
Based on the Price/Forward Earnings ratio, MSS is valued cheaper than 94.87% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.99. MSS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.66
MSS Price Earnings VS Forward Price EarningsMSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

87.18% of the companies in the same industry are more expensive than MSS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.28
EV/EBITDA N/A
MSS Per share dataMSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as MSS's earnings are expected to grow with 35.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MSS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAISON SOLUTIONS INC-A

NASDAQ:MSS (10/14/2025, 8:00:02 PM)

After market: 0.84 +0.03 (+4%)

0.8077

-0.03 (-3.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.5%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.90M
AnalystsN/A
Price TargetN/A
Short Float %0.98%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.66
P/S 0.13
P/FCF 7.28
P/OCF 7.05
P/B 1.57
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0.12
Fwd EY15.01%
FCF(TTM)0.11
FCFY13.73%
OCF(TTM)0.11
OCFY14.19%
SpS6.18
BVpS0.51
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.46%
ROE -10.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.24%
FCFM 1.79%
ROA(3y)0.36%
ROA(5y)0.56%
ROE(3y)72.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.41%
GM growth 5YN/A
F-Score5
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 4.55
Debt/EBITDA N/A
Cap/Depr 7.46%
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.32
Altman-Z 1.47
F-Score5
WACC7.98%
ROIC/WACCN/A
Cap/Depr(3y)250.54%
Cap/Depr(5y)154.53%
Cap/Sales(3y)1.99%
Cap/Sales(5y)1.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-274.13%
EPS Next Y-100%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)64.64%
Revenue growth 3Y43.56%
Revenue growth 5YN/A
Sales Q2Q%-8.38%
Revenue Next Year4.08%
Revenue Next 2Y5.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-218.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year371.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.02%
FCF growth 3Y47.63%
FCF growth 5YN/A
OCF growth 1Y235.76%
OCF growth 3Y47.32%
OCF growth 5YN/A